Clinical Trials Logo

Clinical Trial Summary

A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348(5).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05749861
Study type Interventional
Source Chong Kun Dang Pharmaceutical
Contact
Status Completed
Phase Phase 1
Start date April 22, 2023
Completion date July 18, 2023

See also
  Status Clinical Trial Phase
Completed NCT05549401 - Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 Phase 1
Completed NCT05552495 - Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions Phase 1
Completed NCT04987970 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg Phase 1
Completed NCT04587206 - A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 Phase 1
Completed NCT02933658 - Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers Phase 1
Completed NCT05335044 - Study to Evaluate the Safety and Pharmacokinetics of CKD-331 Phase 1
Completed NCT05245084 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg Phase 1
Completed NCT04883658 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) Phase 1
Completed NCT05698043 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg Phase 1
Completed NCT04660370 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 Phase 1
Completed NCT04673864 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 Phase 1
Completed NCT05192356 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) Phase 1
Completed NCT04694989 - A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) Phase 1
Completed NCT04554953 - A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia